These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 20552565)

  • 21. Structure-activity relationship study of CXCR4 antagonists bearing the cyclic pentapeptide scaffold: identification of the new pharmacophore.
    Tanaka T; Tsutsumi H; Nomura W; Tanabe Y; Ohashi N; Esaka A; Ochiai C; Sato J; Itotani K; Murakami T; Ohba K; Yamamoto N; Fujii N; Tamamura H
    Org Biomol Chem; 2008 Dec; 6(23):4374-7. PubMed ID: 19005596
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Potent inhibitors of human matriptase-1 based on the scaffold of sunflower trypsin inhibitor.
    Fittler H; Avrutina O; Empting M; Kolmar H
    J Pept Sci; 2014 Jun; 20(6):415-20. PubMed ID: 24723440
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Design of potent selective zinc-mediated serine protease inhibitors.
    Katz BA; Clark JM; Finer-Moore JS; Jenkins TE; Johnson CR; Ross MJ; Luong C; Moore WR; Stroud RM
    Nature; 1998 Feb; 391(6667):608-12. PubMed ID: 9468142
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel sst(4)-selective somatostatin (SRIF) agonists. 1. Lead identification using a betide scan.
    Rivier J; Erchegyi J; Hoeger C; Miller C; Low W; Wenger S; Waser B; Schaer JC; Reubi JC
    J Med Chem; 2003 Dec; 46(26):5579-86. PubMed ID: 14667212
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Design of P1' and P3' residues of trivalent thrombin inhibitors and their crystal structures.
    Slon-Usakiewicz JJ; Sivaraman J; Li Y; Cygler M; Konishi Y
    Biochemistry; 2000 Mar; 39(9):2384-91. PubMed ID: 10694407
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Countering cooperative effects in protease inhibitors using constrained beta-strand-mimicking templates in focused combinatorial libraries.
    Reid RC; Pattenden LK; Tyndall JD; Martin JL; Walsh T; Fairlie DP
    J Med Chem; 2004 Mar; 47(7):1641-51. PubMed ID: 15027855
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nonpolar interactions of thrombin S' subsites with its bivalent inhibitor: methyl scan of the inhibitor linker.
    Slon-Usakiewicz JJ; Purisima E; Tsuda Y; Sulea T; Pedyczak A; Féthière J; Cygler M; Konishi Y
    Biochemistry; 1997 Nov; 36(44):13494-502. PubMed ID: 9354617
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serine proteases inhibiting cyanopeptides.
    Radau G
    Pharmazie; 2000 Aug; 55(8):555-60. PubMed ID: 10989830
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cyclotheonamides E2 and E3, new potent serine protease inhibitors from the marine sponge of the genus Theonella.
    Nakao Y; Oku N; Matsunaga S; Fusetani N
    J Nat Prod; 1998 May; 61(5):667-70. PubMed ID: 9599274
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The synthesis of azapeptidomimetic beta-lactam molecules as potential protease inhibitors.
    Malachowski WP; Tie C; Wang K; Broadrup RL
    J Org Chem; 2002 Dec; 67(25):8962-9. PubMed ID: 12467415
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Crystal structure of an elastase-specific inhibitor elafin complexed with porcine pancreatic elastase determined at 1.9 A resolution.
    Tsunemi M; Matsuura Y; Sakakibara S; Katsube Y
    Biochemistry; 1996 Sep; 35(36):11570-6. PubMed ID: 8794736
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structure-based rational design of beta-hairpin peptides from discontinuous epitopes of cluster of differentiation 2 (CD2) protein to modulate cell adhesion interaction.
    Liu J; Li C; Ke S; Satyanarayanajois SD
    J Med Chem; 2007 Aug; 50(17):4038-47. PubMed ID: 17658775
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of putative agouti-related protein(87-132)-melanocortin-4 receptor interactions by homology molecular modeling and validation using chimeric peptide ligands.
    Wilczynski A; Wang XS; Joseph CG; Xiang Z; Bauzo RM; Scott JW; Sorensen NB; Shaw AM; Millard WJ; Richards NG; Haskell-Luevano C
    J Med Chem; 2004 Apr; 47(9):2194-207. PubMed ID: 15084118
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The reactive site of marinostatin, a proteinase inhibitor from marine Alteromonas sp. B-10-31.
    Takano R; Imada C; Kamei K; Hara S
    J Biochem; 1991 Dec; 110(6):856-8. PubMed ID: 1794974
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New insight into the binding mode of peptide ligands at Urotensin-II receptor: structure-activity relationships study on P5U and urantide.
    Grieco P; Carotenuto A; Campiglia P; Gomez-Monterrey I; Auriemma L; Sala M; Marcozzi C; d'Emmanuele di Villa Bianca R; Brancaccio D; Rovero P; Santicioli P; Meini S; Maggi CA; Novellino E
    J Med Chem; 2009 Jul; 52(13):3927-40. PubMed ID: 19432421
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel potent hepatitis C virus NS3 serine protease inhibitors derived from proline-based macrocycles.
    Chen KX; Njoroge FG; Arasappan A; Venkatraman S; Vibulbhan B; Yang W; Parekh TN; Pichardo J; Prongay A; Cheng KC; Butkiewicz N; Yao N; Madison V; Girijavallabhan V
    J Med Chem; 2006 Feb; 49(3):995-1005. PubMed ID: 16451065
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Discovery of inhibitors of the channel-activating protease prostasin (CAP1/PRSS8) utilizing structure-based design.
    Tully DC; Vidal A; Chatterjee AK; Williams JA; Roberts MJ; Petrassi HM; Spraggon G; Bursulaya B; Pacoma R; Shipway A; Schumacher AM; Danahay H; Harris JL
    Bioorg Med Chem Lett; 2008 Nov; 18(22):5895-9. PubMed ID: 18752942
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cyclic peptide analysis of the biologically active loop region in the laminin alpha3 chain LG4 module demonstrates the importance of peptide conformation on biological activity.
    Kato-Takagaki K; Suzuki N; Yokoyama F; Takaki S; Umezawa K; Higo J; Mochizuki M; Kikkawa Y; Oishi S; Utani A; Nomizu M
    Biochemistry; 2007 Feb; 46(7):1952-60. PubMed ID: 17261031
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structural and functional study of an Anemonia elastase inhibitor, a "nonclassical" Kazal-type inhibitor from Anemonia sulcata.
    Hemmi H; Kumazaki T; Yoshizawa-Kumagaye K; Nishiuchi Y; Yoshida T; Ohkubo T; Kobayashi Y
    Biochemistry; 2005 Jul; 44(28):9626-36. PubMed ID: 16008348
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structure-activity relationship study on artificial CXCR4 ligands possessing the cyclic pentapeptide scaffold: the exploration of amino acid residues of pentapeptides by substitutions of several aromatic amino acids.
    Tanaka T; Nomura W; Narumi T; Esaka A; Oishi S; Ohashi N; Itotani K; Evans BJ; Wang ZX; Peiper SC; Fujii N; Tamamura H
    Org Biomol Chem; 2009 Sep; 7(18):3805-9. PubMed ID: 19707686
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.